High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma

Carbohydrate antigen 19‐9 (CA19‐9) fails to demonstrate the predictive value for early detection pancreatic ductal adenocarcinoma (PDAC). Glypican‐1 (GPC1+) exosomes may serve as a noninvasive diagnostic tool to detect early stages of PDAC. Therefore, it is necessary to explore the serum GPC1 levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Cong‐ya, Dong, Yi‐ping, Sun, Xiao, Sui, Xin, Zhu, Hong, Zhao, Ya‐qin, Zhang, Yuan‐yuan, Mason, Clifford, Zhu, Qing, Han, Su‐xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246926/
https://www.ncbi.nlm.nih.gov/pubmed/30358133
http://dx.doi.org/10.1002/cam4.1833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246926/
https://www.ncbi.nlm.nih.gov/pubmed/30358133
http://dx.doi.org/10.1002/cam4.1833

Ejemplares similares